PDF(Pubmed)
Abstract：
Guidelines help clinicians to deliver high-quality care with therapies based on up-to-date evidence. There has been significant progress in the management of heart failure with regards to both medication and cardiac device therapy. These advances have been incorporated into national and international guidelines with varying degrees of success. This article reviews current guidance from the National Institute of Health and Care Excellence in the UK and compares this with European Society of Cardiology guidelines, and evaluates how differences between them may impact on clinical practice.
摘要：
指南帮助临床医生根据最新证据提供高质量的治疗。在药物治疗和心脏装置治疗方面，心力衰竭的管理取得了重大进展。这些进展已被纳入国家和国际准则，取得了不同程度的成功。本文回顾了英国国家健康与护理卓越研究所的现行指南，并将其与欧洲心脏病学会指南进行了比较。并评估它们之间的差异如何影响临床实践。
